Add to ORKGMinimal disease activity (MDA) is an important target in patients with psoriatic arthritis (PsA), however it is also criticised for having a low threshold for patient reported outcomes (PRO).The aim of the study was to assess the prevalence of MDA and its components in patients with PsA and to evaluate disease characteristics and patterns in patients with or without MDA (MDA+ or MDA-)
Background Psoriatic arthritis (PsA) recommendations state that the target of treatment should be re...
To determine the proportion of patients with psoriatic arthritis in the Adalimumab Effectiveness in ...
Objective: The aim of this study was to evaluate minimal disease activity (MDA) assessments in patie...
As in other inflammatory rheumatic diseases, the objective of psoriatic arthritis (PsA) treatment is...
OBJECTIVE: To create minimal disease activity (MDA) criteria for psoriatic arthritis (PsA). With rec...
Objective. To assess how many PsA patients with an acceptable disease state according to the treatin...
Abstract Background Patients with psoriatic arthritis (PsA) experience functional impairment and red...
Objective: To comprehensively assess evidence on the measurement properties of the minimal disease a...
Objective: To comprehensively assess evidence on the measurement properties of the minimal disease a...
Psoriatic arthritis (PsA) is a chronic inflammatory joint disease affecting around 40% of psoriasis ...
Objective. To estimate the frequency of patients with psoriatic arthritis (PsA) achieving minimal di...
In recent years there has been increasing research focusing on the assessment of disease activity in...
Objective: Currently, concerning the evaluation of psoriatic arthritis (PsA), there is no agreement ...
Abstract Background Although psoriatic arthritis is complex and involves multiple domains, recent ad...
Objective: Currently, concerning the evaluation of psoriatic arthritis (PsA), there is no agreement ...
Background Psoriatic arthritis (PsA) recommendations state that the target of treatment should be re...
To determine the proportion of patients with psoriatic arthritis in the Adalimumab Effectiveness in ...
Objective: The aim of this study was to evaluate minimal disease activity (MDA) assessments in patie...
As in other inflammatory rheumatic diseases, the objective of psoriatic arthritis (PsA) treatment is...
OBJECTIVE: To create minimal disease activity (MDA) criteria for psoriatic arthritis (PsA). With rec...
Objective. To assess how many PsA patients with an acceptable disease state according to the treatin...
Abstract Background Patients with psoriatic arthritis (PsA) experience functional impairment and red...
Objective: To comprehensively assess evidence on the measurement properties of the minimal disease a...
Objective: To comprehensively assess evidence on the measurement properties of the minimal disease a...
Psoriatic arthritis (PsA) is a chronic inflammatory joint disease affecting around 40% of psoriasis ...
Objective. To estimate the frequency of patients with psoriatic arthritis (PsA) achieving minimal di...
In recent years there has been increasing research focusing on the assessment of disease activity in...
Objective: Currently, concerning the evaluation of psoriatic arthritis (PsA), there is no agreement ...
Abstract Background Although psoriatic arthritis is complex and involves multiple domains, recent ad...
Objective: Currently, concerning the evaluation of psoriatic arthritis (PsA), there is no agreement ...
Background Psoriatic arthritis (PsA) recommendations state that the target of treatment should be re...
To determine the proportion of patients with psoriatic arthritis in the Adalimumab Effectiveness in ...
Objective: The aim of this study was to evaluate minimal disease activity (MDA) assessments in patie...